| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6100068 | Journal of Crohn's and Colitis | 2013 | 9 Pages |
Abstract
Oral budesonide 9Â mg od (for up to 8Â weeks) may offer a new treatment option for Japanese patients with mild-to-moderate active Crohn's disease.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Yasuo Suzuki, Satoshi Motoya, Masakazu Takazoe, Tadashi Kosaka, Masataka Date, Masahiro Nii, Toshifumi Hibi,